Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, when there have been discussions since 12 January 2015 between members of the Chemotherapy Clinical Reference Group and clinicians on the breast cancer drugs that are to be removed on 12 March 2015 from the Cancer Drugs Fund list; and what the content of those discussions was.

Ministers have regular discussions with NHS England on a range of issues, including the Cancer Drugs Fund (CDF).

NHS England has advised that the Chemotherapy Clinical Reference Group (CRG) met on 9 February 2015 when a paper summarising the outcome of the recent CDF panel was discussed. The CRG membership is made up predominately of clinical members including two breast cancer oncologists.